STAT+: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena

The CEOs of Merck and Johnson & Johnson have agreed to voluntarily testify before the Senate health committee, avoiding a threatened subpoena.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks